Incidence of Malignancy in Multinodular Goiter in Rizgary Teaching Hospital
DOI:
https://doi.org/10.56056/amj.2019.76Keywords:
Malignant, Multinodular goiter, Papillary carcinomaAbstract
Background and objectives: Multinodular goiters have recently been indicated to have an incidence of cancer that approaches that of solitary thyroid nodule. The objective of this study was to determine the incidence and the types of various thyroid malignancies in multinodular goiters in Rizgary Teaching Hospital.
Methods:A retrospective study of 328 consecutive patients with multinodular goiter underwent thyroidectomy at a Rizgary Teaching Hospital in Erbil from May 2013 to Nov 2017. All saved histopathological reports were collected for the patients based on age, sex of the patients with the histopathological results from the histopathological reports. The patients with histopathological report of thyroiditis & solitary thyroid nodule were excluded from the study.
Results: A final pathologic diagnosis of malignancy was found in 12 of 328 (3.7%) of multinodular goiters patients. Larger number of the malignant tumors was found in female patients 11(91.7%). Most common type of malignant tumors was papillary carcinoma 11 (91.7%) of which 10 cases were found in females (90.9%).
Conclusions:We conclude that the incidence of malignancy in mul- tinodular goiters is 3.7% in our patients. The Incidence of malignant tumors in multinodular goiter in female patients is significantly higher than in male patients. The commonest type of malignant tumors in multinodular goiters was papillary carcinoma.
Downloads
References
Williams N, O’Connell PR. Bailey & Love’s Short Practice of Surgery 26E: Crc Press; 2013.
Bauer PS, Murray S, Clark N, Pontes DS, Sippel RS, Chen H. Unilateral thyroidectomy for the treatment of benign multinodular goiter. Journal of surgical research 2013;184(1):514-8.
Grodski S, Brown T, Sidhu S, et al. Increasing incidence of thy- roid cancer is due to increased pathologic detection. Surgery 2008;144(6):1038-43.
Medeiros-Neto G. Multinodular goiter. 2016. Avaialble from: http:// www.thyroidmanager.org/wp-content/uploads/chapters/multinodu- lar-goiter.pdf .
Goitre M-n. The incidence of malignancy in multi-nodular goitre: a prospective study at a tertiary academic centre. Journal of clinical and diagnostic research 2012;6(2):267-70.
Shrestha D, Shrestha S. The incidence of thyroid carcinoma in Mul- tinodular goiter: A retrospective study. Journal of College of Medical Sciences-Nepal 2015;10(4):18-21.
Niedziela M. Pathogenesis, diagnosis and management of thyroid nodules in children. Endocrine-related cancer 2006;13(2):427-53.
Norlén O, Charlton A, Sarkis LM, et al. Risk of malignancy for each Bethesda class in pediatric thyroid nodules. Journal of pediatric surgery 2015;50(7):1147-9.
R?os A, Rodr?guez J, Canteras M, Galindo P, Balsalobre M, Parrilla P. Risk factors for malignancy in multinodular goitres. European journal of surgical oncology 2004;30(1):58-62.
Hsu B, Reeve TS, Guinea AI, Robinson B, Delbridge L. Recur- rent substernal nodular goiter: incidence and management. Surgery 1996;120(6):1072-5.
Torre G, Borgonovo G, Amato A, et al. Surgical management of substernal goiter: analysis of 237 patients. The American surgeon 1995;61(9):826-31.
Sebastian SO, Gonzalez JR, Paricio PP, et al. Papillary thyroid car- cinoma: prognostic index for survival including the histological variety. Archives of Surgery 2000;135(3):272-7.
Yamashita H, Noguchi S, Watanabe S, et al. Thyroid cancer associ- ated with adenomatous goiter: an analysis of the incidence and clinical factors. Surgery today 1997;27(6):495-9.
Memon A, De Gonzalez AB, Luqmani Y, Suresh A. Family history of benign thyroid disease and cancer and risk of thyroid cancer. European Journal of Cancer 2004;40(5):754-60.
McCall A, Jarosz H, Lawrence A, Paloyan E. The incidence of thyroid carcinoma in solitary cold nodules and in multinodular goiters. Surgery 1986;100(6):1128-32.
Hurley DL, Gharib H. Evaluation and management of multinodular goiter. Otolaryngologic Clinics of North America 1996;29(4):527-40.
Hermus AR, Huysmans DA. Treatment of benign nodular thyroid dis- ease. New England Journal of Medicine 1998;338(20):1438-47.
Al-Saleh M, Al-Kattan K. Incidence of carcinoma in multinodular goitre in Saudi Arabia. Journal of the Royal College of Surgeons of Ed- inburgh 1994;39(2):106-8.
Noguchi S, Yamashita H, Murakami N, Nakayama I, Toda M, Ka- wamoto H. Small carcinomas of the thyroid: a long-term follow-up of 867 patients. Archives of Surgery 1996;131(2):187-91.
Luo J, McManus C, Chen H, Sippel R. Are There Predictors Of Ma-lignancy In Patients With Multinodular Goiter? Journal of Surgical Re- search 2011;165(2):274.
Wartofsky L. Increasing world incidence of thyroid cancer: in- creased detection or higher radiation exposure. Hormones (Athens) 2010;9(2):103-8.
Pasieka JL, Lee JA. Surgical Endocrinopathies: Clinical Manage- ment and the Founding Figures: Springer; 2015. Avaialble from: https:// link.springer.com/content/pdf/bfm%3A978-3-319-13662-2%2F1.pdf.
Goitre M. The incidence of malignancy in multi-nodular goitre: a prospective study at a tertiary academic centre. Journal of clinical and diagnostic research 2012;6(2):267-70.
Frates MC, Benson CB, Doubilet PM, et al. Prevalence and distribu- tion of carcinoma in patients with solitary and multiple thyroid nodules on sonography. The Journal of Clinical Endocrinology & Metabolism 2006;91(9):3411-7.
Gandolfi PP, Frisina A, Raffa M. The incidence of thyroid carcinoma in multinodular goiter: retrospective analysis. Acta Bio Medica Atenei Parmensis 2004;75(2):114-7.
Zuberi L, Yawar A, Islam N, Jabbar A. Clinical presentation of thyroid cancer patients in Pakistan-AKUH experience. Journal of pakistan med- ical association 2004;54(10):526-7.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Saad Abdulkadir Muhammad, Tayeb Sabir Kareem
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The copyright on any article published in AMJ (The Scientific Journal of Kurdistan Higher Council of Medical Specialties )is retained by the author(s) in agreement with the Creative Commons Attribution Non-Commercial ShareAlike License (CC BY-NC-SA 4.0)